Drug:
Reaction: PARAESTHESIA
20250101 - 20251231
No. 701 - 800
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 701 | 25714697 |
EU |
66 | 2 |
Chest discomfort, Paraesthesia, |
||||
CARBOPLATIN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 702 | 25714846 |
EU |
30 | 2 |
Headache, Paraesthesia, Nausea, |
||||
SUMATRIPTAN, SUMATRIPTAN SUCCINATE, |
||||
| 703 | 25714869 |
GB |
56 | 2 |
Muscle spasms, Anger, Paraesthesia, Depression, Amnesia, Attention deficit hyperactivity disorder, Psychomotor hyperactivity, Petit mal epilepsy, Hypoacusis, Somnambulism, Asthenia, Hallucination, Aphasia, Fatigue, Abnormal dreams, Abnormal behaviour, Change in sustained attention, Abnormal behaviour, Poor quality sleep, |
||||
MONTELUKAST, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, PROGESTERONE, |
||||
| 704 | 25715399 |
US |
28 | 2 |
Musculoskeletal stiffness, Pallor, Hypoaesthesia, Muscle spasms, Hyperhidrosis, Pain, Movement disorder, Dizziness, Paraesthesia, |
||||
TRISODIUM CITRATE DIHYDRATE, PHENTERMINE HYDROCHLORIDE, |
||||
| 705 | 25715700 |
CA |
||
Adverse drug reaction, Bone cancer, Dyspnoea, Hepatic enzyme abnormal, Hepatic neoplasm, Hormone receptor positive HER2 negative breast cancer, Liver disorder, Metastases to eye, Mucosal inflammation, Neutropenia, Paraesthesia, Skeletal injury, Tachycardia, Suspected counterfeit product, |
||||
GOSERELIN, GOSERELIN, GOSERELIN, FULVESTRANT, TAMOXIFEN CITRATE, TAMOXIFEN CITRATE, TAMOXIFEN CITRATE, TAMOXIFEN CITRATE, PACLITAXEL, PALBOCICLIB, CAPECITABINE, |
||||
| 706 | 25715809 |
US |
58 | 2 |
Flushing, Urticaria, Chest discomfort, Throat tightness, Dizziness, Hypoaesthesia, Paraesthesia, Injection site rash, |
||||
EVOLOCUMAB, |
||||
| 707 | 25715956 |
US |
75 | 2 |
Drug hypersensitivity, Urticaria, Paraesthesia, Hypotension, |
||||
RAMIPRIL, LISINOPRIL, |
||||
| 708 | 25716221 |
CA |
45 | 1 |
Lupus-like syndrome, Arthralgia, Paraesthesia, |
||||
RISANKIZUMAB-RZAA, INFLIXIMAB, |
||||
| 709 | 25716468 |
GB |
56 | 2 |
Muscle spasms, Aphasia, Abnormal behaviour, Hallucination, Petit mal epilepsy, Attention deficit hyperactivity disorder, Depression, Psychomotor hyperactivity, Hypoacusis, Amnesia, Fatigue, Change in sustained attention, Abnormal dreams, Abnormal behaviour, Asthenia, Paraesthesia, Somnambulism, Anger, Poor quality sleep, |
||||
MONTELUKAST SODIUM, MONTELUKAST, PROGESTERONE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 710 | 25716842 |
US |
2 | |
Cerebrovascular accident, Peripheral swelling, Paraesthesia, |
||||
RISANKIZUMAB-RZAA, |
||||
| 711 | 25717034 |
US |
65 | 2 |
Paraesthesia, Hypoaesthesia, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 712 | 25717328 |
US |
62 | 1 |
Paraesthesia, Skin burning sensation, Rash, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 713 | 25717625 |
EU |
34 | 2 |
Musculoskeletal stiffness, Sensory loss, C-reactive protein increased, Hemiparesis, Paraesthesia, Corynebacterium infection, Staphylococcal infection, Acute disseminated encephalomyelitis, Bone abscess, Osteomyelitis fungal, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, METHYLPREDNISOLONE, VORICONAZOLE, AMPHOTERICIN B, AMPHOTERICIN B, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, FLUCYTOSINE, |
||||
| 714 | 25717694 |
36 | 1 | |
Myelitis, Guillain-Barre syndrome, Swelling of eyelid, Autoimmune disorder, Visual acuity reduced, Photosensitivity reaction, Hypersensitivity, Keratitis, Injection site discomfort, Hypoaesthesia, Sensory loss, Musculoskeletal stiffness, Asthenia, Movement disorder, Loss of proprioception, Cough, Sputum increased, Increased upper airway secretion, Influenza, Paraesthesia, Infection, Pain, Granuloma, Product communication issue, Multiple use of single-use product, Device difficult to use, Wrong technique in device usage process, Drug effective for unapproved indication, Vision blurred, General physical health deterioration, Ill-defined disorder, Decreased immune responsiveness, Malaise, Off label use, |
||||
DEXAMETHASONE, TOBRAMYCIN, TOBRAMYCIN SULFATE, TOBRAMYCIN SOLUTION, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, AMOXICILLIN, |
||||
| 715 | 25718195 |
CA |
40 | 2 |
Decreased appetite, Hypersensitivity, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver function test increased, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Therapeutic product effect decreased, Treatment failure, Maternal exposure during pregnancy, Overdose, Underdose, Intentional product use issue, Product label confusion, Product use in unapproved indication, Off label use, Product quality issue, |
||||
APREMILAST, ERENUMAB-AOOE, APREMILAST, CELECOXIB, CELECOXIB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, GOLIMUMAB, GOLIMUMAB, AZATHIOPRINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, MEPOLIZUMAB, OXYCODONE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RAMIPRIL, RAMIPRIL, RAMIPRIL, RANITIDINE HYDROCHLORIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 716 | 25721187 |
80 | 1 | |
Paraesthesia, Hypoaesthesia, Hypoaesthesia, Peripheral coldness, Hypoaesthesia, |
||||
EZETIMIBE, LEVOTHYROXINE SODIUM, EZETIMIBE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, TICAGRELOR, ASPIRIN, ASPIRIN 81 MG DELAYED RELEASE TABLETS, |
||||
| 717 | 25708704 |
GB |
46 | 2 |
Cognitive disorder, Burning sensation, Hypoaesthesia, Paraesthesia, Head discomfort, |
||||
SUMATRIPTAN, SUMATRIPTAN SUCCINATE, |
||||
| 718 | 25709332 |
IN |
||
Cardiac arrest, Metabolic acidosis, Shock, Acute kidney injury, Pulmonary oedema, Overdose, Toxicity to various agents, Hyperhidrosis, Paraesthesia, Hypoaesthesia, Dizziness, Vomiting, |
||||
AMLODIPINE, |
||||
| 719 | 25709353 |
US |
64 | 1 |
Neuropathy peripheral, Paraesthesia, Neck pain, Hypoaesthesia, Drug specific antibody present, |
||||
ADALIMUMAB, ADALIMUMAB, |
||||
| 720 | 25709456 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Breast cancer stage III, Condition aggravated, Confusional state, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fibromyalgia, General physical health deterioration, Helicobacter infection, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Maternal exposure during pregnancy, Memory impairment, Migraine, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Osteoarthritis, Paraesthesia, Pemphigus, Pericarditis, Psoriatic arthropathy, Rash, Stomatitis, Swelling, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Wound infection, Abdominal pain upper, Rheumatoid arthritis, |
||||
TOCILIZUMAB, RITUXIMAB, |
||||
| 721 | 25709482 |
US |
73 | 1 |
Paraesthesia, Chills, Hyperhidrosis, Hot flush, |
||||
RELUGOLIX, PREDNISONE, |
||||
| 722 | 25709750 |
US |
77 | 2 |
Paraesthesia, Pain in extremity, Visual impairment, Peripheral swelling, Contusion, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 723 | 25709936 |
EU |
68 | 1 |
Gait disturbance, Polyneuropathy, Paraesthesia, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, GOSERELIN, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 724 | 25710093 |
EU |
62 | 2 |
Paraesthesia, Pain, Nausea, Tinnitus, |
||||
PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, FENTANYL, |
||||
| 725 | 25710314 |
CA |
36 | 2 |
Paraesthesia, Swelling of eyelid, |
||||
RAVULIZUMAB, RAVULIZUMAB, RAVULIZUMAB, ALBUTEROL SULFATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 726 | 25711035 |
US |
5 | 2 |
Eczema, Pain of skin, Skin weeping, Arthralgia, Gait disturbance, Alopecia, Pain in extremity, Fall, Feeling abnormal, Paraesthesia, |
||||
DUPILUMAB, |
||||
| 727 | 25711453 |
CA |
60 | 1 |
Neuropathy peripheral, Burning sensation, Hypoaesthesia, Muscle spasms, Allodynia, Pain, Paraesthesia, Central pain syndrome, |
||||
OXALIPLATIN, CAPECITABINE, VORTIOXETINE, |
||||
| 728 | 25711462 |
CH |
58 | 2 |
White blood cell count decreased, Neutrophil count decreased, Paraesthesia, Lymphocyte count decreased, Lymphocyte count decreased, Lymphocyte count decreased, Lymphocyte count decreased, Platelet count decreased, Platelet count decreased, |
||||
FULVESTRANT, RIBOCICLIB, RIBOCICLIB, |
||||
| 729 | 25711474 |
EU |
74 | 2 |
Muscular weakness, Injection site haematoma, Paraesthesia, Injection site pain, Pain, |
||||
TERIPARATIDE, DICLOFENAC SODIUM, FENTANYL, TRAMADOL HYDROCHLORIDE, FAMOTIDINE, |
||||
| 730 | 25711773 |
US |
11 | 2 |
Sleep disorder, Drug hypersensitivity, Urticaria, Skin burning sensation, Paraesthesia, Pruritus, Rash macular, Pyrexia, |
||||
AGALSIDASE BETA, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, EPINEPHRINE, ADRENALINUM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, WATER, STERILE WATER, STERILE WATER FOR INJECTION, CETIRIZINE HYDROCHLORIDE, ERGOCALCIFEROL, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, FAMOTIDINE, OSELTAMIVIR PHOSPHATE, MAGNESIUM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, CALCIUM CARBONATE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, |
||||
| 731 | 25711853 |
CA |
36 | 1 |
Myelitis, Swelling of eyelid, Autoimmune disorder, Visual acuity reduced, Photosensitivity reaction, Keratitis, Guillain-Barre syndrome, Hypersensitivity, Sensory loss, Musculoskeletal stiffness, Movement disorder, Loss of proprioception, Sputum increased, Increased upper airway secretion, Pain, Granuloma, Vision blurred, General physical health deterioration, Ill-defined disorder, Malaise, Decreased immune responsiveness, Hypoaesthesia, Asthenia, Cough, Infection, Paraesthesia, Influenza, Injection site discomfort, Device difficult to use, Drug effective for unapproved indication, Wrong technique in device usage process, Multiple use of single-use product, Product communication issue, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, AMOXICILLIN, TOBRAMYCIN, |
||||
| 732 | 25712069 |
GB |
60 | 1 |
Paraesthesia, Miliaria, Skin burning sensation, Erythema, Sensitisation, Hyperaesthesia, Pain of skin, Pruritus, Dry skin, |
||||
BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, |
||||
| 733 | 25712072 |
EU |
73 | 2 |
Paraesthesia, Pain in extremity, Arthralgia, |
||||
ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, |
||||
| 734 | 25712214 |
TW |
53 | 2 |
Cardiopulmonary failure, Dyspnoea, Wheezing, Toxicity to various agents, Chest discomfort, Palpitations, Pain, Sensory disturbance, Speech disorder, Hiccups, Pyrexia, Gastrointestinal disorder, Diarrhoea, Haemorrhoidal haemorrhage, Haemorrhoids, Tongue discomfort, Taste disorder, Dry mouth, Hypoaesthesia, Paraesthesia, Hyperhidrosis, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, CARBOPLATIN, TRASTUZUMAB, PERTUZUMAB, TENOFOVIR ALAFENAMIDE, |
||||
| 735 | 25712252 |
GB |
2 | |
Myalgia, Nausea, Vomiting, Paraesthesia, Headache, Dizziness postural, |
||||
| 736 | 25712270 |
EU |
46 | 2 |
Cholelithiasis, Palmar-plantar erythrodysaesthesia syndrome, Paraesthesia, Dysaesthesia, Blister, Erythema, Dyshidrotic eczema, Transaminases increased, Diarrhoea, Fatigue, |
||||
ABEMACICLIB, ABEMACICLIB, LETROZOLE, LETROZOLE TABLETS, GOSERELIN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, RAMIPRIL, |
||||
| 737 | 25712350 |
EU |
24 | 2 |
Bradycardia, General physical condition abnormal, Restlessness, Tension, Vision blurred, Urinary incontinence, Derealisation, Depressed mood, Loss of personal independence in daily activities, Hypoaesthesia, Brain fog, Emotional poverty, Eczema, Hypotonia, Sick leave, Dysuria, Sinus arrhythmia, Aggression, Irritability, Thinking abnormal, Mood swings, Anxiety, Paraesthesia, Fatigue, Somnolence, Product communication issue, Inappropriate schedule of product discontinuation, Impulsive behaviour, Depersonalisation/derealisation disorder, Illusion, Behaviour disorder, Crying, Swelling face, Weight increased, Logorrhoea, Memory impairment, Electric shock sensation, Muscle twitching, Circadian rhythm sleep disorder, Delusion of grandeur, Amnesia, |
||||
| 738 | 25712584 |
EU |
48 | 1 |
Immune-mediated hyperthyroidism, Paraesthesia, |
||||
OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 739 | 25703121 |
US |
1 | |
Dry skin, Paraesthesia, Pruritus, |
||||
DUPILUMAB, |
||||
| 740 | 25703179 |
US |
47 | 2 |
Discomfort, Product quality issue, Hypoaesthesia, Paraesthesia, Asthenia, |
||||
ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, |
||||
| 741 | 25703427 |
US |
1 | |
Paraesthesia, |
||||
TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 742 | 25703477 |
US |
44 | 2 |
Tremor, Paraesthesia, Headache, Hypertension, Tremor, |
||||
LENALIDOMIDE, |
||||
| 743 | 25703483 |
CA |
||
Condition aggravated, Infusion site extravasation, Poor venous access, Neuralgia, Arthralgia, Lupus-like syndrome, Paraesthesia, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, MESALAMINE, METHOTREXATE, METHOTREXATE SODIUM, MESALAMINE, PREDNISONE, |
||||
| 744 | 25703879 |
CA |
||
Blood potassium decreased, Blood sodium decreased, Brain injury, Condition aggravated, Cortisol decreased, Crohn^s disease, Dehydration, Enteritis, Flat affect, Gait disturbance, Gallbladder operation, Irritable bowel syndrome, Nasal congestion, Renal pain, Transient ischaemic attack, Weight increased, Abdominal discomfort, Cough, Paraesthesia, COVID-19, Illness, Gastroenteritis, Fatigue, Headache, Influenza, Dyspnoea, Constipation, Bronchitis, Nasopharyngitis, Pneumonia, Pyrexia, Back pain, Abdominal pain upper, Therapeutic response shortened, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PREDNISONE, |
||||
| 745 | 25704294 |
US |
2 | |
Tongue injury, Pain, Paraesthesia, |
||||
IBANDRONATE SODIUM, |
||||
| 746 | 25704425 |
US |
57 | 1 |
Paraesthesia, Vomiting, Product dose omission in error, |
||||
RIPRETINIB, |
||||
| 747 | 25704445 |
US |
1 | |
Postoperative wound infection, Skin laceration, Skin weeping, Swelling, Pollakiuria, Dry skin, Nocturia, Dehydration, Cough, Hypotension, Paraesthesia, Blood glucose decreased, Fatigue, Upper respiratory tract infection, |
||||
AMOXICILLIN, CARVEDILOL, CARVEDILOL, SACUBITRIL AND VALSARTAN, GLIPIZIDE, EMPAGLIFLOZIN, |
||||
| 748 | 25704557 |
EU |
48 | 1 |
Immune-mediated hyperthyroidism, Paraesthesia, |
||||
OXALIPLATIN, OXALIPLATIN, PEMBROLIZUMAB, PEMBROLIZUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, TRASTUZUMAB, TRASTUZUMAB, |
||||
| 749 | 25704602 |
US |
2 | |
Injection site swelling, Paraesthesia, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 750 | 25704837 |
US |
19 | 1 |
Pain, Tetany, Vision blurred, Hypoaesthesia, Muscle spasms, Paraesthesia, Heart rate decreased, |
||||
TRISODIUM CITRATE DIHYDRATE, NASAL, SALINE, (SALINE), |
||||
| 751 | 25705355 |
EU |
35 | 2 |
General physical condition abnormal, Tension, Bradycardia, Paraesthesia, Vision blurred, Urinary incontinence, Derealisation, Depressed mood, Loss of personal independence in daily activities, Somnolence, Emotional poverty, Brain fog, Impulsive behaviour, Depersonalisation/derealisation disorder, Illusion, Behaviour disorder, Amnesia, Delusion of grandeur, Circadian rhythm sleep disorder, Electric shock sensation, Weight increased, Swelling face, Restlessness, Hypotonia, Logorrhoea, Fatigue, Dysuria, Fatigue, Aggression, Muscle twitching, Sinus arrhythmia, Irritability, Thinking abnormal, Mood swings, Anxiety, Sick leave, Crying, Memory impairment, Eczema, Inappropriate schedule of product discontinuation, Product communication issue, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 752 | 25705457 |
US |
69 | 1 |
Photosensitivity reaction, Feeling hot, Paraesthesia, Pain, |
||||
CAPSAICIN, |
||||
| 753 | 25705884 |
GB |
1 | |
Musculoskeletal stiffness, Paraesthesia, |
||||
| 754 | 25705971 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Abdominal pain upper, Adverse reaction, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Coeliac disease, Condition aggravated, Confusional state, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug-induced liver injury, Duodenal ulcer perforation, Dyspepsia, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower respiratory tract infection, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product label confusion, Product quality issue, Off label use, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Therapeutic product effect decreased, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Dry mouth, Adverse event, Hospitalisation, |
||||
ABATACEPT, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, ATOMOXETINE, ATOMOXETINE, AZATHIOPRINE, AZATHIOPRINE SODIUM, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE ACETATE, MINOCYCLINE, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, MEPOLIZUMAB, OXYCODONE HYDROCHLORIDE, OXYCODONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, RETINOL, RETINOL, TOFACITINIB, TOFACITINIB, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 755 | 25706022 |
CA |
72 | 2 |
Glomerular filtration rate decreased, Nerve compression, Musculoskeletal stiffness, Joint swelling, Adverse event, Back pain, Gait disturbance, Headache, Deafness, Drug intolerance, Limb discomfort, Inflammation, Bursitis, Polyarthritis, Musculoskeletal discomfort, Movement disorder, Pain, Electric shock sensation, Arthralgia, Hypersensitivity, Pain in extremity, Dry mouth, Tinnitus, Pain in jaw, Disease recurrence, Blood creatinine increased, Disease progression, Paraesthesia, Tachycardia, Inflammatory marker increased, Feeling abnormal, Neck pain, Hypoaesthesia, |
||||
DICLOFENAC, DICLOFENAC SODIUM, LEFLUNOMIDE, LOSARTAN, TOFACITINIB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROSUVASTATIN CALCIUM, TRIAMTERENE AND HYDROCHLOROTHIAZIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
| 756 | 25706485 |
EU |
1 | |
Gait disturbance, Paraesthesia, |
||||
NITROUS OXIDE, |
||||
| 757 | 25706829 |
US |
65 | 2 |
Poor peripheral circulation, Paraesthesia, Arthralgia, |
||||
DUPILUMAB, |
||||
| 758 | 25707039 |
EU |
||
Neurotoxicity, Paraesthesia, Pain in extremity, Bradyphrenia, Disorientation, Gait disturbance, Dysarthria, Vomiting, Dysphagia, Nervous system disorder, Neuropathy peripheral, Somnolence, Dizziness, Nausea, Burning sensation, Condition aggravated, Peripheral sensory neuropathy, |
||||
METRONIDAZOLE, AMOXICILLIN, ENALAPRIL, HYDROCHLOROTHIAZIDE, SIMVASTATIN, LEFLUNOMIDE, HYDROXYCHLOROQUINE, PREDNISONE, |
||||
| 759 | 25707057 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain, Abdominal pain upper, Adverse drug reaction, Adverse event, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein increased, Condition aggravated, Confusional state, Contraindicated product administered, Decreased appetite, Depression, Diarrhoea, Discomfort, Dizziness, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Epilepsy, Exposure during pregnancy, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Hypocholesterolaemia, Impaired healing, Inflammation, Infusion related reaction, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver injury, Lower respiratory tract infection, Lung disorder, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Night sweats, No adverse event, Obesity, Off label use, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Product quality issue, Product use in unapproved indication, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, |
||||
BUPRENORPHINE, OXYCODONE HYDROCHLORIDE, OXYCODONE, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN AND CODEINE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, APREMILAST, LEFLUNOMIDE, CYANOCOBALAMIN, LORAZEPAM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, QUETIAPINE FUMARATE, QUETIAPINE, RISEDRONATE SODIUM, SULFASALAZINE, FISH OIL, |
||||
| 760 | 25707120 |
EU |
35 | 2 |
Constipation, Headache, Vertigo, Asthenia, Paraesthesia, Oesophageal ulcer, |
||||
OLAPARIB, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, |
||||
| 761 | 25707131 |
CA |
36 | 1 |
Myelitis, Guillain-Barre syndrome, Swelling of eyelid, Autoimmune disorder, Visual acuity reduced, Photosensitivity reaction, Hypersensitivity, Keratitis, Injection site discomfort, Hypoaesthesia, Sensory loss, Musculoskeletal stiffness, Asthenia, Movement disorder, Loss of proprioception, Cough, Sputum increased, Increased upper airway secretion, Influenza, Paraesthesia, Infection, Pain, Granuloma, Product communication issue, Multiple use of single-use product, Device difficult to use, Wrong technique in device usage process, Drug effective for unapproved indication, Vision blurred, General physical health deterioration, Ill-defined disorder, Decreased immune responsiveness, Malaise, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, TOBRAMYCIN, DEXAMETHASONE, AMOXICILLIN, |
||||
| 762 | 25707313 |
CA |
40 | 2 |
Arthropathy, Blister, Breast cancer stage III, Coeliac disease, Contraindicated product administered, Dizziness, Drug ineffective, Drug intolerance, Drug-induced liver injury, Duodenal ulcer perforation, Epilepsy, Helicobacter infection, Hypoaesthesia, Hepatitis, Injection site reaction, Intentional product use issue, Joint range of motion decreased, Lip dry, Maternal exposure during pregnancy, Liver injury, Lower respiratory tract infection, Migraine, Muscular weakness, Nasopharyngitis, Off label use, Paraesthesia, Pemphigus, Pericarditis, Pneumonia, Psoriatic arthropathy, Rheumatoid arthritis, Rheumatic fever, Stomatitis, Systemic lupus erythematosus, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, |
||||
| 763 | 25707589 |
GB |
31 | 1 |
Chest discomfort, Anxiety, Vomiting, Hyperhidrosis, Paraesthesia, Muscle spasms, Malaise, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 764 | 25707850 |
US |
2 | |
Stomatitis, Oral pain, Eating disorder, Pain, Fatigue, Feeling abnormal, Decreased activity, Neuropathy peripheral, Paraesthesia, Hypoaesthesia, Discomfort, Nausea, Vomiting, |
||||
OLAPARIB, |
||||
| 765 | 25707983 |
US |
2 | |
Paraesthesia, Device deployment issue, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
| 766 | 25697967 |
IN |
50 | 2 |
Acute kidney injury, Metabolic acidosis, Toxicity to various agents, Intentional overdose, Non-cardiogenic pulmonary oedema, Capillary leak syndrome, Shock, Paraesthesia, Hypoaesthesia, Hypoaesthesia, Confusional state, Hypotension, Dizziness, Hyperhidrosis, Vomiting, |
||||
AMLODIPINE, |
||||
| 767 | 25698196 |
US |
64 | 1 |
Spinal fusion surgery, Paraesthesia, Hypoaesthesia, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 768 | 25699106 |
CA |
||
Blood pressure fluctuation, Chest discomfort, Confusional state, Oxygen saturation decreased, Dyspnoea, Hyperhidrosis, Infusion related reaction, Nausea, Paraesthesia, Pruritus, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ADALIMUMAB-BWWD, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, PREDNISONE, PREGABALIN, |
||||
| 769 | 25699132 |
US |
58 | 2 |
Reactive gastropathy, Febrile neutropenia, Anaemia, Fatigue, Nausea, Paraesthesia, Pancytopenia, |
||||
CARBOPLATIN, CISPLATIN, PACLITAXEL, LEVOTHYROXINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PACLITAXEL, |
||||
| 770 | 25699440 |
IN |
50 | 2 |
Overdose, Cardiac arrest, Oliguria, Metabolic acidosis, Hyperhidrosis, Dizziness, Paraesthesia, Hypoaesthesia, Confusional state, Hypotension, |
||||
AMLODIPINE, |
||||
| 771 | 25699659 |
EU |
71 | 1 |
Radiation pneumonitis, Superinfection bacterial, Cough, Pyrexia, Hypoxia, Bone pain, Night sweats, Dyspnoea exertional, Respiratory failure, Productive cough, General physical health deterioration, Paraesthesia, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, CARBOPLATIN, VINORELBINE, RANITIDINE, RANITIDINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 772 | 25700211 |
US |
2 | |
Weight decreased, Decreased appetite, Paraesthesia, Blister, Catheter placement, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, TUCATINIB, |
||||
| 773 | 25700438 |
EU |
39 | 2 |
Muscular weakness, Paraesthesia, Gait disturbance, Headache, Tremor, Palpitations, Hepatic enzyme increased, Hot flush, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PROGESTERONE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, KETOPROFEN, |
||||
| 774 | 25700552 |
US |
||
Paraesthesia, |
||||
TIRZEPATIDE, |
||||
| 775 | 25700667 |
US |
1 | 1 |
Decreased appetite, Crying, Insomnia, Nasopharyngitis, Pain, Rhinorrhoea, Nasal congestion, Depressed mood, Eczema, Erythema, Pruritus, Lichenification, Paraesthesia, Rash macular, |
||||
DUPILUMAB, |
||||
| 776 | 25700885 |
US |
37 | 1 |
Palpitations, Hypoaesthesia, Paraesthesia, Arthralgia, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 777 | 25701549 |
US |
||
Paraesthesia, |
||||
ISTRADEFYLLINE, AMANTADINE, CELECOXIB, FISH OIL, SERTRALINE HYDROCHLORIDE, |
||||
| 778 | 25701589 |
US |
77 | 1 |
Lower limb fracture, Fall, Paraesthesia, Hypoaesthesia, |
||||
DAROLUTAMIDE, |
||||
| 779 | 25701871 |
US |
2 | |
Paraesthesia, Headache, Application site pain, Inappropriate schedule of product administration, |
||||
MINOXIDIL, |
||||
| 780 | 25701995 |
US |
72 | 2 |
Paraesthesia, Drug ineffective, |
||||
MINOXIDIL, CALCIUM, |
||||
| 781 | 25702049 |
US |
61 | 2 |
Hypoaesthesia, Paraesthesia, Headache, |
||||
PALBOCICLIB, LETROZOLE, |
||||
| 782 | 25702370 |
US |
2 | |
Paraesthesia, Pruritus, Rash pruritic, |
||||
ALIROCUMAB, |
||||
| 783 | 25702400 |
US |
2 | |
Taste disorder, Paraesthesia oral, Chest pain, Burning sensation, Nausea, Heart rate increased, Paraesthesia, Drug hypersensitivity, |
||||
ALIROCUMAB, |
||||
| 784 | 25702717 |
US |
2 | |
Skin tightness, Pain in extremity, Paraesthesia, |
||||
ALIROCUMAB, |
||||
| 785 | 25702951 |
US |
||
Paraesthesia, Muscle twitching, |
||||
ZURANOLONE, |
||||
| 786 | 25703006 |
CA |
||
Loss of consciousness, Dizziness, Hyperhidrosis, Hypoaesthesia, Hypotension, Paraesthesia, Off label use, Intentional product use issue, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PREDNISONE, |
||||
| 787 | 25688680 |
US |
48 | 2 |
Product storage error, Product after taste, Vulvovaginal pruritus, Urine odour abnormal, Somnolence, Paraesthesia, Nasopharyngitis, COVID-19, Abdominal discomfort, Petechiae, Rash, Pruritus, Flushing, |
||||
DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, OXCARBAZEPINE, BACLOFEN, LEVOTHYROXINE SODIUM, ALENDRONATE SODIUM, ATORVASTATIN CALCIUM, AMITRIPTYLINE HYDROCHLORIDE, ERGOCALCIFEROL, RIMEGEPANT SULFATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, CALCIUM GLUCONATE, CETIRIZINE HYDROCHLORIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ACETAMINOPHEN, |
||||
| 788 | 25689015 |
CA |
43 | 2 |
Gait disturbance, Gastrointestinal disorder, General symptom, Grip strength decreased, Headache, Hypersensitivity, Ill-defined disorder, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal stiffness, Myositis, Nail disorder, Nasopharyngitis, Night sweats, Obesity, Oedema peripheral, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Pruritus, Psoriasis, Psoriatic arthropathy, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rheumatic fever, Sinusitis, Sleep disorder, Sleep disorder due to a general medical condition, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, Wound infection, X-ray abnormal, Product quality issue, Product use in unapproved indication, Intentional product use issue, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 789 | 25689529 |
GB |
2 | |
Paraesthesia, Hypoaesthesia, |
||||
| 790 | 25689581 |
EU |
28 | 2 |
Pain in extremity, Visual impairment, Wrong technique in product usage process, Injection site swelling, Paraesthesia, Spinal pain, Chromatopsia, Anisocoria, Injection site haematoma, Scintillating scotoma, Eye pain, Electric shock sensation, |
||||
LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, FREMANEZUMAB-VFRM, FREMANEZUMAB-VFRM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 791 | 25689583 |
EU |
71 | 1 |
Azotaemia, Asthenia, Paraesthesia, Constipation, Pain in extremity, |
||||
OXALIPLATIN, OXALIPLATIN, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, CAPECITABINE, CAPECITABINE, CAPECITABINE, CAPECITABINE, |
||||
| 792 | 25689968 |
US |
49 | 2 |
Transient ischaemic attack, Hemiparesis, Vision blurred, Paraesthesia, Headache, |
||||
OSILODROSTAT, |
||||
| 793 | 25690157 |
US |
1 | |
Paraesthesia, |
||||
RIMEGEPANT SULFATE, |
||||
| 794 | 25690853 |
GB |
56 | 1 |
Paraesthesia, Product temperature excursion issue, Poor quality product administered, Off label use, Off label use, |
||||
METHOTREXATE SODIUM, FOLIC ACID, CLOPIDOGREL, CLOPIDOGREL BISULFATE, PANTOPRAZOLE, |
||||
| 795 | 25690970 |
US |
2 | |
Paraesthesia, |
||||
SUZETRIGINE, |
||||
| 796 | 25691461 |
US |
2 | |
Diabetes mellitus, Pain in extremity, Musculoskeletal stiffness, Paraesthesia, Pruritus, |
||||
INCLISIRAN, INCLISIRAN, INCLISIRAN, |
||||
| 797 | 25691539 |
US |
24 | 1 |
Loss of consciousness, Dysgeusia, Tremor, Hypoaesthesia, Nausea, Muscle spasms, Anxiety, Dizziness, Pallor, Chills, Peripheral coldness, Abdominal pain, Hyperhidrosis, Hypoaesthesia oral, Paraesthesia oral, Paraesthesia, Nasopharyngitis, Abdominal discomfort, |
||||
TRISODIUM CITRATE DIHYDRATE, NASAL, SALINE, (SALINE), |
||||
| 798 | 25691858 |
CA |
43 | 2 |
Memory impairment, Hypertension, Hypoaesthesia, Impaired healing, Infection, Infusion related reaction, Injury, Insomnia, Joint stiffness, Laryngitis, Liver function test increased, Migraine, Loss of personal independence in daily activities, Lower limb fracture, Lupus vulgaris, Lupus-like syndrome, Mobility decreased, Muscular weakness, Musculoskeletal stiffness, Nausea, Oedema, Oedema peripheral, Muscle injury, Osteoporosis, Pain in extremity, Pneumonia, Prescribed overdose, Prescribed underdose, Pruritus, Pulmonary fibrosis, Pyrexia, Red blood cell Heinz bodies present, Retinitis, Muscle spasms, Rheumatic fever, Rheumatoid factor positive, Road traffic accident, Sciatica, Seronegative arthritis, Sinusitis, Sleep disorder, Sleep disorder due to a general medical condition, Spinal fusion surgery, Spondylitis, Musculoskeletal pain, Swollen joint count increased, Tachycardia, Upper respiratory tract infection, Visual impairment, Walking aid user, Weight decreased, Nail disorder, Nasopharyngitis, Night sweats, No adverse event, Obesity, Irritable bowel syndrome, Off label use, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Product quality issue, Product use in unapproved indication, Joint range of motion decreased, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Joint swelling, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia areata, Amnesia, Anti-cyclic citrullinated peptide antibody negative, Lip dry, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Neuropathic arthropathy, Arthropathy, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Bone erosion, Liver injury, Breast cancer stage III, Bronchitis, C-reactive protein increased, Non-cardiac chest pain, Condition aggravated, Confusional state, Contusion, Crohn^s disease, Decreased appetite, Deep vein thrombosis postoperative, Lower respiratory tract infection, Delirium, Depression, Diarrhoea, Disability, Discomfort, Dislocation of vertebra, Dizziness, Drug-induced liver injury, Duodenal perforation, Dyspepsia, Lung disorder, Dyspnoea, Ear infection, Exostosis, Fatigue, Fibromyalgia, Folliculitis, Foot deformity, Gait disturbance, Gait inability, General physical health deterioration, Maternal exposure during pregnancy, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic cirrhosis, Hepatic enzyme increased, Hip arthroplasty, Hypercholesterolaemia, Hypersensitivity, |
||||
TRAMADOL HYDROCHLORIDE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LAMOTRIGINE, LISINOPRIL, LORAZEPAM, MAGNESIUM, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, ABATACEPT, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ERENUMAB-AOOE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RANITIDINE HYDROCHLORIDE, RISEDRONATE SODIUM, RITUXIMAB, SULFASALAZINE, GOLIMUMAB, TOFACITINIB, TOPIRAMATE, TOPIRAMATE SPINKLE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CANDESARTAN, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 799 | 25700045 |
32 | 2 | |
Migraine, Paraesthesia, |
||||
SUMATRIPTAN, SUMATRIPTAN SUCCINATE, |
||||
| 800 | 25690945 |
35 | 2 | |
Neuropathy peripheral, Paraesthesia, Anal inflammation, Vulvovaginal inflammation, Pelvic floor dysfunction, Insomnia, |
||||
OFLOXACIN OTIC, OFLOXACIN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30
